The aim of the current study was to collect clinical normative data for the Clinical Impairment Assessment questionnaire (CIA) and the Eating Disorder Examination Questionnaire (EDE-Q) from adult patients with eating disorders (EDs). This study also examined unique contributions of eating disorder (ED) symptoms on levels of ED-related impairment. A sample of 667 patients, 620 females and 47 males, was recruited from six specialist centres across Norway. The majority of the sample (40.3%) was diagnosed with eating disorder not otherwise specified (EDNOS), 34.5% had bulimia nervosa (BN) and 25.2% were diagnosed with anorexia nervosa (AN). There were significant differences for global EDE-Q and CIA scores between females and males. In the female sample, significant differences were found on several EDE-Q subscales between the AN and BN group, and between the AN and EDNOS group. No significant differences were found between the diagnostic groups on the CIA. In the male sample, no significant differences were found between diagnostic groups on the EDE-Q or CIA. A multiple regression analysis revealed that 46.8% of the variance in impairment as measured by the CIA was accounted for by ED symptoms. Body mass index, eating concern, shape/weight concern and binge eating served as significant, unique predictors of impairment. The results from the present study contribute to the interpretation of EDE-Q and CIA scores in ED samples.
Introduction
Structured clinical interviews are widely viewed as the most accurate method to determining eating disorder (ED) diagnoses and when assessing illness severity. They are designed to help identify core ED pathology, an essential first step in informing treatment. Although clinical interviews provide in-depth information about ED specific cognitions and behaviours, they have the disadvantage of being time consuming and costly to administer. The development and use of ED-specific self-report questionnaires has helped alleviate some of these drawbacks, with two of the most frequently-used questionnaires being the Eating Disorder Examination Questionnaire (EDE-Q) (1) and the Clinical Impairment Assessment (CIA) questionnaire (2) . Whereas the EDE-Q was developed as a self-report version of the Eating Disorder Examination Interview (3) to measure key attitudes and behavioural features of EDs, the CIA was designed to assess functional impairment related to EDs. The CIA is intended to supplement the EDE-Q by providing information about impairment secondary to eating disorder symptoms.
There exist large sets of normative data collected from community and population-based samples for the EDE-Q (4-10) and to a lesser extent, the CIA (2, 11, 12) . However, little is known about the distribution of scores among individuals with EDs in clinical samples, and even less is known in terms of the diagnostic distribution of scores within and between the various ED diagnoses. Further, with a few exceptions (13) (14) (15) , existing data from the EDE-Q and the CIA have been collected for female samples (16) (17) (18) (19) (20) (21) , leaving behavioural features, attitudes and ED-related impairment among males relatively unexplored. As clinical norms are important for treatment planning and the measurement of clinically significant change (22) , and as no such norms exist for the Norwegian versions of the EDE-Q and CIA, the primary aim of our study was to establish clinical norms for the EDE-Q and the CIA using data collected from male and female patients presenting with a range of diagnoses based upon the DSM-IV (23) .
Although the CIA was developed as a supplement to the EDE-Q, and should be used in tandem (2, 24) there are surprisingly few studies investigating the association between ED symptoms and functional impairment. To the authors' knowledge, merely one previously published study has investigated the impact of ED psychopathology (as assessed using the EDE-Q) on psychosocial impairment (as assessed using the CIA) (25) . Due to the lack of research on this topic, we know little about how the observed impairment in EDs compares between different ED diagnoses, and whether certain ED symptoms have a greater impact on impairment compared to others.
Consequently, the second aim of our study was to investigate how individual ED symptoms and features contribute to functional impairment in patients diagnosed with different ED diagnoses.
Methods

Participants and Procedure
Participants were inpatients and outpatients recruited from six specialist eating disorder centres in Norway, who completed the EDE-Q and CIA questionnaire at the start of treatment. All patients met ICD-10 criteria for an eating disorder (F50.0-F50.9). The sample consisted of 667 patients (93% females and 7% males), with a mean age of 28.2 (SD = 8.6, range 16-61) years.
For this study, ICD-10 diagnoses were transformed to DSM-IV diagnoses, resulting in a diagnostic distribution of 25% patients with anorexia nervosa (AN), 35% with bulimia nervosa (BN) and 40% with eating disorder not otherwise specified (EDNOS). The EDNOS category (N=269) is a summary of the following diagnostic categories: F50.1 (Atypical AN), N=117, F50.3 (Atypical BN), N=64, F50.4 (Overeating associated with other psychological disturbances), N=2, F50.5 (Vomiting associated with other psychological disturbances), N=1, F50.8, N=21 (Other Specified ED), N=21 and F50.9 (Unspecified ED), N=64. Diagnostic and demographic information was collected from medical records. The Norwegian Regional Committee for Medical and Health Research Ethics approved the study.
Measures
The Eating Disorder Examination Questionnaire (EDE-Q, v. 16.0) (1) measures attitudinal features of eating disorders and core eating disorder behaviours (binge eating and inappropriate compensatory behaviours) over the past 28 days. It has four clinically-derived subscales each consisting of five to eight items: dietary restraint, eating concern, weight concern, and shape concern, which are used to calculate a global EDE-Q score. The 22-attitudinal items that comprise the global score are each rated using seven-point forced-choice format (0-6), with higher scores reflecting greater pathology. The Norwegian translation of the EDE-Q has demonstrated convergent validity with the EDE-interview (2) in a non-clinical sample of female university students, and similar to a recent, Finnish, validation (26), satisfactory internal consistency for both the global (α =.94), and subscales scores for restraint (α = .75), eating concern (α = .78), shape concern (α = .90) and weight concern (α =.81) (7) . The internal consistency in this study was also satisfactory (global EDE-Q α =.94, restraint α = .82, eating concern α = .75, shape concern (α = .88), and weight concern (α =.82).
The Clinical Impairment Assessment (CIA, version 3.0) questionnaire is a 16-item self-report measure of functional impairment secondary to eating disorder psychopathology (2) . Items probe impairment in life domains typically affected by EDs such as mood, self-perception, cognitive functioning, interpersonal functioning and work performance over the past 4 weeks. Respondents rate items using a 4-point scale with responses ranging from "not at all" to 'a lot", providing both general and domain-specific indices of functional impairment. A global score and three subscale scores (personal impairment, cognitive impairment, and social impairment) can be calculated.
Total scores range from 0 to 48, with higher scores representing greater impairment. The Norwegian version has shown satisfactory psychometric properties and excellent internal consistency for the global score (α =.92), as well as for the three subscale scores personal, social and cognitive impairment (α = .93, α = .84, and α = .86), respectively (11) in a non-clinical sample of young adult females recruited at universities in Norway. In this study the internal consistency was also satisfactory (CIA global score α = .92, personal impairment α = .83, social impairment α = .85, cognitive impairment α = .85).
Statistical Analyses
All statistical analyses were performed using IBM SPSS Statistics 21. Student t-test and Pearson's chi-square test were used to explore differences between groups. Analysis of variance (ANOVA) was used to explore differences of EDE-Q and CIA scores between all diagnostic groups for each gender separately. The post hoc Scheffé method was used to investigate significant differences between specific diagnostic groups. Effect sizes were calculated using for analysis of variance (small p 2 = .01, medium p 2 = .06, and large p 2 = .14). We used a hierarchical multiple regression analysis to explore the influence of unique individual ED symptoms on ED-related impairment. The CIA global score was used as the dependent variable, with BMI, the EDE-Q subscales eating concern and restraint, as well as the EDE-Q items on binge eating, self-induced vomiting, and laxative misuse, entered as independent variables.
Because of a high inter-correlation (Pearson r = .88), the EDE-Q subscales weight concern and shape concern were averaged together to create an aggregate weight/shape concern variable. Gender and age were added to the model to control for the influence of these (potential) confounders. Statistical significance was set at the conventional level of p < .05 for all model parameters.
We used the thresholds reported in Welch et al. (28) for occurrence of disordered eating behaviour (see Table 3 ). Not all patients responded to the EDE-Q items on dietary restraint, excessive exercise, objective binge eating, self-induced vomiting and laxative misuse.
Consequently, results were presented in valid percent (i.e. percentage that does not include missing cases). Table 2 . Males scored significantly lower compared to females on the EDE-Q global score (t(51.28) = 2.29, p = .026, d = .37) as well as on the weight concern (t(665) = 2.22, p = .027, d = .33), shape concern (t(665) = 2.61, p = .009, d = .39), and eating concern (t(665) = 2.25, p = .005, d = .40), EDE-Q subscales but not on restraint subscale (t(665) = 1.51, p = .133, d = .21). Using Bonferroni correction of multiple comparisons for the four subscales (p < .013) only shape and eating concern were statistically different between genders. Males also scored significantly lower on the CIA global score (t(49,88) = 2,19, p = .033, d = 0.37) and on the CIA subscales personal (t(49.52) = 2.17, p = .035, d = .37, and cognitive impairment (t(597) = 3.03, p = .005, d = .46), but not on the social impairment subscale (t(49.82) = 0.86, p = .393, d = .15). Using Bonferroni correction of multiple comparisons for the three subscales (p < .017) only cognitive impairment was statistically different between genders.
Results
Demographics and diagnostic distribution
One-way analysis of variance (ANOVA) showed a significant difference in EDE-Q global scores between diagnostic groups among females (F(2,617) = 8.37, p < .001, p 2 = .03) but no significant differences between diagnostic groups in males (F(2,44) = 0.10, p = .91, p 2 = .004).
The multivariate analysis of variance (MANOVA) indicated an overall effect for EDE subscales for females, Wilks' Lambda = .62, F (8, 1230) = 6.65, p <.001, p 2 = .04. Using univariate analyses for the female sample, there were significant differences between diagnostic groups (p<.001) for eating concern (F(2,617) = 11.38, p < .001, p 2 = .04), shape concern (F(2,617) = 6.58, p = .001, p 2 = .02) and weight concern (F(2,617) = 12.90, p < .001, p 2 = .04) subscales.
Post hoc tests showed significantly lower subscale scores (3 of 4 subscales) in the AN group compared to the BN group (p <.05 -p<.001), and lower scores in the AN group compared to the EDNOS group (p <.01 -p<.001) in the female sample. There were no statistical differences for CIA total score between diagnostic groups among females (F(2,550)=1.57, p=.21, p 2 = .006) and males (F(2,43) = 1.00, p = .38, p 2 = .04).
[Insert Table 2 Table 3 presents the proportion of females and males respectively, engaging in the following eating disordered behaviours: dietary restraint, episodes of excessive exercise, objective binge eating, self-induced vomiting and laxative misuse. Using Chi-square test, there were no statistical differences between genders in the proportion engaging in different eating disorder behaviors.
[Insert Table 3 here]
Contributions of ED symptoms to ED-related impairment
The results from the regression analyses revealed that the first model (age and gender) accounted for a small (1.8%) contribution to the variance in the CIA total score and only gender had a significant contribution (p <.01). After the entry of the seven independent variables (BMI, EDE-Q subscales eating concern, restraint and shape/weight concern, binge eating, self-induced vomiting, and laxative misuse), the total variance explained by the second model as a whole was 46.8% (p < .001), with the seven variables explaining an additional 44.9% of the variance in EDassociated impairment beyond age and gender. In the third model only significant variables in model two were included (BMI, binge eating, EDE-Q subscales eating concern, restraint and shape/weight concern) and the results showed that restraint subscale did not have a significant contribution to global CIA. The final fourth model with significant variables in model three (BMI, binge eating, EDE-Q subscales eating concern and shape/weight concern) made unique, significant contributions to the level of impairment assessed by the CIA total score and explained 46.5% of the variance. As shown in table 4, eating concern had the biggest contribution to CIA total score (highest standardized beta value) followed by shape/weight concern, BMI and binge eating episodes in the final model 4.
[Insert Table 4 here]
Discussion
The primary aim of the current study was to establish clinical norms for the EDE-Q and the CIA for male and female in-and outpatients diagnosed with an ED. Male patients scored significantly lower on both the EDE-Q and CIA than females. Female AN patients scored significantly lower than BN and EDNOS female patients on EDE-Q, but no difference in CIA scores were found between diagnostic groups. We also wanted to investigate how individual ED symptoms and features contributed to functional impairment, and our findings showed that approximately 50% of ED-related impairment could be explained by ED symptoms assessed using the CIA.
In Norway, community norms have been established for both the EDE-Q (31) and the CIA (11) in healthy female adults, but to date, there are no studies investigating norms in clinical ED to find a significant difference between the AN and EDNOS groups on the EDE-Q restraint subscale, and in reproducing their results reporting significant differences on all remaining EDE-Q subscales except eating concern. In addition, the occurrence of vomiting and laxative misuse among females was less frequent in their study (55% versus 62% and 12% versus 21%, respectively). This was true for all diagnostic groups, and was also applicable to the male sample.
In our female clinical sample, we found somewhat higher levels of ED impairment compared to previous reports (2, 7, 28, 31 ). Yet we reported a lower global CIA score compared to a UK clinical sample (30) . These differences may be due to sample differences in treatment level, age, gender or diagnostic categories. Similar to Welch et al. (28) , we found significantly lower scores on the CIA for males than for females. However, contrary to the findings by Welch and colleagues, who found lower CIA scores for individuals with EDNOS and BED, we failed to find significant differences between diagnostic categories. In our study, patients with BED were included in the EDNOS group since BED is not a formal diagnosis in the ICD-10. Although similar in diagnostic distribution, it should be noted that the Welch et al. sample was considerably larger than ours (N = 2383 vs. 667), with a considerably lower proportion of males (2.4% vs. 7.0 %) (19) . Any similarities or differences between these two studies should therefore be interpreted carefully, potentially influenced by sample sizes and gender discrepancies.
When investigating the unique contributions of individual ED symptoms to impairment, our results revealed that nearly half (47%) of the impairment experienced by our patients was directly attributable to ED psychopathology. Specifically, eating concern, weight/shape concern, BMI and binge eating made significant unique contributions to the regression model. These numbers correspond well to those reported in Hovrud and De Young (25) , who found that ED psychopathology accounted for 46% of the variance in clinical impairment. They reported that following the inclusion of depression in the model, the total explained variance increased from 46 % to 58.6%, with binge eating, weight/shape concern and depression serving as unique predictors of impairment (18) . Unfortunately, we were unable to assess depression in our study, and thus, were unable to explore its predictive value on ED-related impairment. Similar to Hovruds and De Young (25) , binge eating and weight/shape concern were significant predictors of impairment in our model. In contrast, however, we found that eating concern and BMI accounted for unique variance in CIA scores. These differences may be due to the impact of depression in the Hovrud and De Young's regression analyses, and this warrants further investigation.
Although community norms have been established for both the EDE-Q (31) and the CIA (11) in Norway, this is the first study to report normative data in a clinical ED sample, and to further investigate the association between these two well-established clinical instruments. The present study included a large representative clinical sample, consisting of data collected from six treatment centres, including both female and male in-and outpatients. The study is further strengthened by the sample size, which is considerably larger than the majority of previously published studies on clinical CIA and EDE-Q norms. However, there are some limitations to consider. Diagnoses were clinically derived according to ICD-10 criteria and we lacked diagnostic data needed to establish AN subtypes. Also, the EDNOS group in the current study consists of a combination of residual ED diagnostic categories. Any inferences about, and comparisons to this group should therefore be made with caution. Results from the male sample should also be interpreted cautiously as reliable between subject differences are practically nondetectable in a sample size this small. We did not have data on comorbidity, and thus, we were unable to investigate the potential effects of comorbidity such as anxiety or depression on ED symptomatology and clinical impairment.
